New York State Common Retirement Fund’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXO
VP
RG
TCM
AC
New York State Common Retirement Fund's ALXO Position: Q2 2025 in Review
New York State Common Retirement Fund sold out of ALX Oncology (ALXO) in Q2 2025, closing a stake of 12,522 shares — an estimated $7.8K sold.
New York State Common Retirement Fund first reported a position in ALXO in Q3 2020 and held it in 19 quarters. The position peaked at $2.08M in Q3 2021. 61 funds tracked by Wall St. Rank hold ALXO as of Q2 2025.
- New York State Common Retirement Fund reported no remaining ALX Oncology position as of Q2 2025 after selling out during the quarter.
- New York State Common Retirement Fund sold 12,522 ALX Oncology shares in Q2 2025, an estimated $7.8K.
- New York State Common Retirement Fund first reported a position in ALX Oncology in Q3 2020 and held it in 19 quarters.
- New York State Common Retirement Fund's ALX Oncology position peaked at $2.08M in Q3 2021.
- 61 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2025.
Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.